MobiHealth News March 31, 2025
The company will use the funds for AI research and to advance its programs in clinical development.
Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.
Thrive Capital led the round, with participation from GV (Google Ventures) and existing investor Alphabet.
WHAT IT DOES
Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind.
The aim of AlphaFold 3 is to accurately predict the structure of proteins, DNA, RNA and ligands and how they interact. A ligand is an ion or molecule with a functional group that binds to a central metal...
Today's Sponsors
Today's Sponsor